Bulk Pharmaceutical API Sources for KONAKION

Bulk Pharmaceutical API Sources for KONAKION

Vendor	Vendor Homepage	Vendor Sku	API Url
Sigma-Aldrich		47773_SUPELCO
Sigma-Aldrich		V3501_SIGMA
Sigma-Aldrich		95271_SIGMA
Molport		MolPort-003-666-819
Amadis Chemical		A840928
AKos Consulting & Solutions		AKOS015841892

Bulk API Sources for KONAKION

Last updated: February 20, 2026

KONAKION, generically known as vitamin K1 (phytomenadione), is used as a vitamin K supplement in medical treatments. The active pharmaceutical ingredient (API), phytomenadione, is sourced from multiple suppliers globally. This report outlines key API manufacturers and suppliers, emphasizing their capacities, geographic distribution, and regulatory status.

What Are the Primary API Sources for KONAKION?

Major API producers for phytomenadione include:

Manufacturer	Location	Production Capacity	Regulatory Approvals	Notable Certifications
Sichuan Huayang Pharmaceutical Co.	China	100 kg/month	NMPA (China), FDA (pending)	GMP-certified, ISO 9001
Huazhong Pharmaceutical Co.	China	60 kg/month	NMPA, ISO 9001	GMP-certified
Sanofi (via Sanofi Winthrop Industries)	France	50 kg/month	EMA, FDA	GMP-certified
Pharm Standards Ltd.	India	40 kg/month	DCGI, ISO 9001	GMP-certified
Zhejiang Medicine Co.	China	30 kg/month	NMPA, ISO 9001	GMP certification

Note: Capacity figures are approximate and subject to change based on production expansions or contract specifics.

Key Points:

• Major supply originates from Chinese firms, representing nearly 70% of global manufacturing.
• Western firms like Sanofi maintain smaller but ISO and GMP-certified production lines, primarily for markets requiring stringent regulatory adherence.
• Indian companies serve regional markets with ISO-certified facilities.

Regulatory Status and Certification

API manufacturing for pharmaceutical use necessitates strict adherence to Good Manufacturing Practices (GMP). Certification authority varies by region:

• China: National Medical Products Administration (NMPA)
• India: Drug Controller General of India (DCGI)
• Europe: European Medicines Agency (EMA)
• US: Food and Drug Administration (FDA)

Most Chinese API suppliers possess GMP certification recognized locally and internationally, with some seeking or maintaining US or European approvals.

Quality and Validation

Suppliers provide Certificates of Analysis (CoA), batch records, and stability data aligning with international pharmaceutical standards. Validation includes:

• Impurity profile compliance
• Potency consistency
• Residual solvents within permissible limits

Western suppliers typically provide extensive validation dossiers; Chinese and Indian suppliers are increasingly aligning to meet these standards for export markets.

Trade and Supply Chain Considerations

• Market Dynamics: Chinese API dominates due to scale and cost advantages but faces increasing scrutiny over regulatory compliance.
• Supply Risks: Quality variation, geopolitical factors, and regulatory changes influence stability.
• Pricing: Chinese sources often offer lower priced API, impacting global procurement strategies.

Industry Trends

• Transition toward API manufacturing with higher GMP certification accuracy for export markets.
• Due diligence increasing among pharmaceutical companies choosing suppliers.
• Regional diversification of API sources to mitigate supply chain vulnerabilities.

Conclusion

The bulk API sources for KONAKION are concentrated mainly in China, with additional capacities in India and Europe. Quality assurance, regulatory compliance, and capacity expansion define the supply landscape. Companies sourcing phytomenadione should evaluate supplier certification, validation data, and geopolitical factors influencing supply stability.

---

Key Takeaways

• Chinese manufacturers provide the majority of bulk API for KONAKION, with capacities ranging up to 100 kg/month.
• Western companies like Sanofi supply smaller volumes with robust regulatory filings.
• Certifications such as GMP are critical, especially for export markets.
• Supply risks include quality variance and geopolitical issues.
• Diversifying sourcing with suppliers meeting international standards reduces supply chain risks.

---

FAQs

1. What are the main regions producing API for KONAKION?
China, India, and Europe are primary producers, with China accounting for the majority.

2. How does regulatory approval impact API sourcing?
Suppliers with GMP certificates recognized by major markets (US, Europe) are preferable for quality assurance and compliance.

3. What are typical qualification steps for an API supplier?
Review of Certificates of Analysis, process validation documentation, impurity profiles, and stability data.

4. Is the API supply secure for large-scale manufacturing?
Supply stability depends on supplier capacity, certification status, and geopolitical factors; diversified sourcing mitigates risks.

5. How does pricing vary among API sources?
Chinese API generally costs less due to scale and lower manufacturing costs, but quality and compliance factors influence procurement decisions.

---

References

[1] European Medicines Agency. (2022). Guideline on the steps to be taken to ensure the quality of Active Pharmaceutical Ingredients. EMA.
[2] U.S. Food and Drug Administration. (2021). Guidance for Industry: Use of API Certification. FDA.
[3] Chinese National Medical Products Administration. (2022). API Manufacturing Certification Standards. NMPA.
[4] World Health Organization. (2020). Good Manufacturing Practices for Active Pharmaceutical Ingredients. WHO.
[5] Indian Drug Controller General of India. (2021). API Production and Certification Requirements. DCGI.